Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuru Hashida

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 2020
Strictness and Transparency in Approval Process of Medical Products: Japanese SituationMitsuru Hashida
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2022
Advocation and advancements of EPR effect theory in drug delivery science: A commentaryMitsuru Hashida
Advanced Drug Delivery Reviews|June 23, 2020
Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overviewMitsuru Hashida
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 8, 2005
[In-silico prediction of pharmacokinetic properties]Mitsuru Hashida
Drug Metabolism and Pharmacokinetics|November 19, 2004
In silico approaches for predicting ADME properties of drugsFumiyoshi Yamashita, Mitsuru Hashida
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Pharmaceutical device of IFN]Yuriko Higuchi, Mitsuru Hashida
Advanced Drug Delivery Reviews|January 3, 2013
Pharmacokinetic considerations for targeted drug deliveryFumiyoshi Yamashita, Mitsuru Hashida
Drug Metabolism and Pharmacokinetics|July 3, 2007
Targeted delivery systems of small interfering RNA by systemic administrationShigeru Kawakami, Mitsuru Hashida
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Immunotherapy against peritoneal dissemination by immunostimulatory CpG DNA]Yukari Kuramoto, Mitsuru Hashida
Expert Opinion on Drug Delivery|April 28, 2006
Inhibition of tumour metastasis by targeted delivery of antioxidant enzymesMakiya Nishikawa, Mitsuru Hashida
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Clinical Pharmacology and Therapeutics|September 1, 2020
Strictness and Transparency in Approval Process of Medical Products: Japanese SituationMitsuru Hashida
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 28, 2022
Advocation and advancements of EPR effect theory in drug delivery science: A commentaryMitsuru Hashida
Advanced Drug Delivery Reviews|June 23, 2020
Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overviewMitsuru Hashida
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 8, 2005
[In-silico prediction of pharmacokinetic properties]Mitsuru Hashida
Drug Metabolism and Pharmacokinetics|November 19, 2004
In silico approaches for predicting ADME properties of drugsFumiyoshi Yamashita, Mitsuru Hashida
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[Pharmaceutical device of IFN]Yuriko Higuchi, Mitsuru Hashida
Advanced Drug Delivery Reviews|January 3, 2013
Pharmacokinetic considerations for targeted drug deliveryFumiyoshi Yamashita, Mitsuru Hashida
Drug Metabolism and Pharmacokinetics|July 3, 2007
Targeted delivery systems of small interfering RNA by systemic administrationShigeru Kawakami, Mitsuru Hashida
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Immunotherapy against peritoneal dissemination by immunostimulatory CpG DNA]Yukari Kuramoto, Mitsuru Hashida
Expert Opinion on Drug Delivery|April 28, 2006
Inhibition of tumour metastasis by targeted delivery of antioxidant enzymesMakiya Nishikawa, Mitsuru Hashida
Pageof 25